Thank you for subscribing!
Finfeed Archived Jun 17, 2021
Following the launch of two new CBD-based products under the CBII brand, Bod Australia Limited (ASX: BDA) today announced that it has broadened its sales footprint in the United Kingdom via two new online retailers.
Finfeed Archived Jun 04, 2021
The expansion of its comprehensive distribution agreement with leading nutritional supplements company Route2 Pharm Pvt Ltd, will allow for distribution of Creso Pharma Limited's (ASX: CPH, FRA: 1X8) hemp derived therapeutic products sold under the cannaQIX® and CannaDOL brands into Ecuador.
Finfeed Archived Mar 17, 2021
Bod Australia (ASX: BDA) is a cannabis centric healthcare company, with well-branded premium, proven and trusted products within two distinct verticals: Medical Cannabis and CBD and Hemp Consumer products.
Finfeed Archived Dec 21, 2020
Creso Pharma Limited (ASX: CPH, FRA: 1X8) has secured regulatory approval from the Ministry of Agriculture and Animal Feed in Uruguay (Ministerio de Ganadaria, Agricultura y Pesca) through its commercial partner Adler Laboratories, Uruguay for its line of animal health products, anibidiol®.
Get expert stock analysis direct in your inbox
Finfeed Archived Dec 15, 2020
Creso Pharma (ASX: CPH) is positioned to significantly benefit from a TGA decision to down-schedule low dose CBD preparations.
Finfeed Archived Dec 07, 2020
Creso Pharma Limited (ASX: CPH; FRA: 1X8) has advised that the US House of Representatives has passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act.
Finfeed Archived Nov 30, 2020
Creso Pharma (ASX: CPH) has provided a promising update regarding the regulatory status of cannabidiol (CBD) products in Europe.
Finfeed Archived Nov 26, 2020
The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia, which could hellp stocks such as Creso Pharma (ASX: CPH).
Join Our Mailing List
